In line with these in vitro studies, in our cohort of clinical samples we identified up-regulation of APE1 in the post-treatment tumor samples, providing further evidence for the evolution of treatment-acquiring resistance mechanisms. This evidence concerns the gene APEX1 and neoplasm.